Title: Introduction to Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein
Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein, also known as Tumor Necrosis Factor Receptor 1 (TNFR1), is a cell surface receptor that plays a crucial role in the immune response and inflammation. This protein is produced through recombinant technology, making it a valuable tool for research and therapeutic applications. In this article, we will discuss the structure, activity, and applications of Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein.
Structure of Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein
Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein is a type I transmembrane glycoprotein that belongs to the TNF receptor superfamily. It is composed of 455 amino acids and has a molecular weight of approximately 55 kDa. The extracellular domain of this protein contains four cysteine-rich domains, which are important for ligand binding. The intracellular domain contains a death domain, which is essential for signaling and activation of downstream pathways.
Activity of Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein
Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein is the primary receptor for tumor necrosis factor-alpha (TNF-α), a pro-inflammatory cytokine that is involved in various physiological and pathological processes. Upon binding to TNF-α, CD120a/TNFRSF1A/TNFR1 Protein forms a trimeric complex, which leads to the activation of downstream signaling pathways. This results in the production of cytokines, chemokines, and other inflammatory mediators, leading to the recruitment of immune cells and the initiation of an immune response.
Applications of Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein
Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein has a wide range of applications in research and medicine. Here are some of the main applications of this protein:
1. Research: Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein is commonly used in research to study the role of TNF-α in various diseases and conditions. It can be used to investigate the signaling pathways activated by TNF-α and the effects of blocking or activating these pathways.
2. Drug development: TNF-α is a major therapeutic target for the treatment of inflammatory diseases such as rheumatoid arthritis, Crohn’s disease, and psoriasis. Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein can be used to screen potential drugs that can block the interaction between TNF-α and its receptor, thereby reducing inflammation.
3. Diagnosis: The levels of TNF-α and its receptor have been found to be elevated in several diseases, making them potential biomarkers for diagnosis and disease monitoring. Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein can be used in diagnostic assays to measure the levels of TNF-α and its receptor in patient samples.
4. Immunotherapy: Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein has been investigated as a potential immunotherapeutic agent for the treatment of cancer. By targeting TNF-α, it can modulate the immune response and enhance the anti-tumor activity of immune cells.
5. Vaccine development: TNF-α has been shown to play a role in the immune response to viral infections. Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein can be used in vaccine development to enhance the immune response against viral antigens.
Conclusion
Recombinant Human CD120a/TNFRSF1A/TNFR1 Protein is a vital tool for studying the role of TNF-α in various diseases and conditions. Its structure and activity make
There are no reviews yet.